Results 71 to 80 of about 62,350 (252)
Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
Journal of Investigative Medicine High Impact Case Reports, 2014 Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ...
Martin F. Dietrich MD, PhD +3 more
doaj +1 more source
Imaging of giant cell tumor of bone
Indian Journal of Orthopaedics, 2007 Giant cell tumor (GCT) of bone is a benign but locally aggressive and destructive lesion generally occurring in skeletally mature individuals. Typically involving the epiphysiometaphyseal region of long bones, the most common sites include the distal femur, proximal tibia and distal radius.
Purohit, Shaligram, Pardiwala, Dinshaw N
openaire +3 more sources
New opportunities for bioscaffold‐enabled spinal cord injury repair
BMEMat, EarlyView.Schematic illustration of bioscaffolds for spinal cord injury repair. We summarize the effects of bioscaffold properties on SCI repair, highlight different types of bioscaffolds, various fabrication strategies, and in vivo transformations for the clinical development of SCI‐repairing bioscaffolds.
Xiaoqing Qi +11 more
wiley +1 more source
Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1 [PDF]
, 2006 Background Neurofibromatosis 1 (NF1) is an autosomal dominantly inherited disorder caused by a spectrum of mutations affecting the Nf1 gene. Affected patients develop benign and malignant tumors at an increased frequency.
Edwards, Paul C. +5 more
core +1 more source
Marine silicon for biomedical sustainability
BMEMat, EarlyView.Schematic illustrating marine silicon for biomedical engineering. Abstract Despite momentous divergence from oceanic origin, human beings and marine organisms exhibit elemental homology through silicon utilization. Notably, silicon serves as a critical constituent in multiple biomedical processes.
Yahui Han +3 more
wiley +1 more source
Do we need internal fixation devices for giant cell tumors around knee joint? An outcome study
Journal of Orthopaedic Diseases and Traumatology, 2018 Introduction: Giant cell tumors around the knee joint are the most common aggressive benign tumors. Several limb sparing and limb ablation surgeries are practiced with varying level of success.
Ritesh Runu +4 more
doaj +1 more source
Extramedullary Plasmacytoma of Soft Tissues and Gingiva [PDF]
, 2012 Extramedullary plasmacytoma (EMP) is a rare plasma cell neoplasm of soft tissue without bone marrow involvement or other systemic characteristics of multiple myeloma. It accounts for 3% of all plasma cell tumors.
Jena, M, Kaler, AK, Shankar, A
core
Management of post‐implant fibrous dysplasia in the maxilla: A case study
Clinical Advances in Periodontics, EarlyView.Abstract Background Fibrous dysplasia is generally rare, and even rarer in older adults. Special care is needed when altering the alveolar bone in these cases, especially if an implant is involved. This case study highlights such a scenario. Methods This case study details the experience of a 63‐year‐old African American female who presented with a ...
Yousef Taha Y. Amrou +4 more
wiley +1 more source
Case Reports in Medicine, 2010 Giant-cell tumor of bone occurred in the distal end of the ulna is extremely uncommon. A 23-year-old male had a giant-cell tumor occurred in the distal end of the ulna.
Akio Minami +5 more
doaj +1 more source
Giant cell tumor of the distal ulna: a case report
Journal of Medical Case Reports, 2012 Introduction Several cases of long bone giant cell tumor have been reported in the literature. We report the case of a patient with a giant cell tumor in the distal ulna. This is very unusual, with a reported incidence of 0.45 to 6%.
Vanni Daniele +4 more
doaj +1 more source